Eulerpool Terminal
The edge that pays for itself.
Current Protagonist Therapeutics forecasts and price targets in August 2026
Ø Analyst Price Targets
102.55 USD
-32.36 %
Median
104.04 USD
-31.38 %
Max
123.90 USD
Min
65.65 USD
Last Price
151.61 USD
Buy
17
Hold
2
Sell
0
The average target price for Protagonist Therapeutics is 102.55 USD. (-32.36 % below the current price)
The median price target of Protagonist Therapeutics is 104.04 USD.
Stock analysts from many renowned investment banks are closely examining the Protagonist Therapeutics stock. They conclude their professional Protagonist Therapeutics stock analyses with a clear recommendation for the Protagonist Therapeutics stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-03-01 | 17 | 2 | 0 | — |
| 2026-02-01 | 17 | 2 | 0 | 102.55 USD |
| 2026-02-01 | 17 | 2 | 0 | 102.55 USD |
| 2026-01-01 | 17 | 2 | 0 | 97.84 USD |
| 2025-12-01 | 18 | 2 | 0 | 96.12 USD |
| 2025-12-01 | 18 | 2 | 0 | 92.53 USD |
Protagonist Therapeutics Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Protagonist Therapeutics in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 542.00 M USD | 302.00 M USD | 4.75 USD |
| 2027e | 200.00 M USD | -8.00 M USD | -0.13 USD |
| 2028e | 351.00 M USD | 95.00 M USD | 1.49 USD |